Kayla Randle is a pharmacist who is specialized in Oncology in Jonesboro, Georgia. Patients can reach her at 2400 Mount Zion Pkwy, Suite 116, Jonesboro or contact her on 770-603-4265. Active license number of Kayla Randle is RPH027788 for Oncology in Georgia. Kayla Randle is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Kayla Randle speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Kayla Randle
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
2400 Mount Zion Pkwy, Suite 116, Jonesboro, Georgia, 30236-2500
Phone:
770-603-4265
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Kayla Randle are as mentioned below.
NPI Number:
1063952752
NPI Enumeration Date:
01 Mar, 2017
NPI Last Update On:
01 Mar, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Kayla Randle are as mentioned below.
Specialization
License Number
State
Status
Oncology
RPH027788
Georgia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
747 Ralph Mcgill Blvd Ne, Unit 1241 Atlanta, Georgia
Zip:
30312-1127
Phone Number:
--
Fax Number:
--
Patients can reach Kayla Randle at 2400 Mount Zion Pkwy, Suite 116, Jonesboro, Georgia or can call on phone at 770-603-4265.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.